United States trademark law

Fuze Optimizes Communication Networks with New Patent for Address Book Management

Retrieved on: 
Thursday, July 9, 2020
Technology, Mobile, Wireless, Other Communications, Communications, Software, Networks, Internet, Data management, Consumer electronics, Intellectual property law, Patent offices, Intellectual property organizations, International Searching and Preliminary Examining Authorities, United States Patent and Trademark Office, United States trademark law, Patent

Fuze , the leading cloud-based communications provider for the modern global enterprise, today announced that it has been awarded a new patent for advanced address book management, further enabling seamless communication for Fuze users.

Key Points: 
  • Fuze , the leading cloud-based communications provider for the modern global enterprise, today announced that it has been awarded a new patent for advanced address book management, further enabling seamless communication for Fuze users.
  • The U.S. Patent and Trademark Office (USPTO) issued Fuze U.S. Patent No.
  • The invention automatically augments the contact and/or biographical information stored in users address books across computers and other personal devices, such as phones and tablets, pulling publicly available information sent and received via different communication and social networks.
  • This new patent enriches user address books to create a web of information that enhances collaboration and productivity.

ILIAS Biologics Granted Key Patent for Exosome-based Drug Delivery System in the United States

Retrieved on: 
Tuesday, July 7, 2020
Life sciences, Articles, Intellectual property law, United States Patent and Trademark Office, United States trademark law, Patent and Trademark Office, Biopharmaceutical, Patent, Exosome complex

DAEJEON, South Korea, July 7, 2020 /PRNewswire/ -- ILIAS Biologics Inc. (the "Company" or "ILIAS"), a global leader in exosome-based therapeutics, announced today that the Company has been granted a key exosome engineering patent by the United States Patent and Trademark Office (USPTO).

Key Points: 
  • DAEJEON, South Korea, July 7, 2020 /PRNewswire/ -- ILIAS Biologics Inc. (the "Company" or "ILIAS"), a global leader in exosome-based therapeutics, announced today that the Company has been granted a key exosome engineering patent by the United States Patent and Trademark Office (USPTO).
  • "We are very pleased to see that by granting this patent, the United States patent office has recognized ILIAS's innovations in the exosome engineering space.
  • ILIAS Biologics Inc. (previously Cellex Life Sciences, Inc.) was established in 2015 in South Korea to develop exosome-based therapeutics.
  • To learn more about ILIAS Biologics Inc, visit our website at www.iliasbio.com .

SolarWinds Expands Distribution Relationship With ALSO

Retrieved on: 
Tuesday, June 23, 2020
Data management, Security, Technology, Software, Networks, Hardware, Brand management, Intellectual property law, Product management, Brands, Information technology management, System administration, Marketing, SolarWinds, Computer networking, Trademark, Service mark, United States trademark law

SolarWinds (NYSE:SWI) is a leading provider of powerful and affordable IT management software.

Key Points: 
  • SolarWinds (NYSE:SWI) is a leading provider of powerful and affordable IT management software.
  • Our focus on the user and commitment to excellence in end-to-end hybrid IT management has established SolarWinds as a worldwide leader in solutions for network and IT service management, application performance, and managed services.
  • The SolarWinds, SolarWinds & Design, Orion, and THWACK trademarks are the exclusive property of SolarWinds Worldwide, LLC or its affiliates, are registered with the U.S. Patent and Trademark Office, and may be registered or pending registration in other countries.
  • All other SolarWinds trademarks, service marks, and logos may be common law marks or are registered or pending registration.

Petition.ai Launches the First Comprehensive Searchable Database of USPTO Patent Petition Documents

Retrieved on: 
Thursday, June 18, 2020
Intellectual property law, Patent law, United States Patent and Trademark Office, United States trademark law, Patent and Trademark Office, Outline of patents, Reed Tech

CHICAGO, June 18, 2020 /PRNewswire-PRWeb/ -- Petition.ai LLC ("Petition.ai") is excited to announce the launch of the first comprehensive searchable database of publicly available patent petition documents filed with the United States Patent and Trademark Office ("USPTO").

Key Points: 
  • CHICAGO, June 18, 2020 /PRNewswire-PRWeb/ -- Petition.ai LLC ("Petition.ai") is excited to announce the launch of the first comprehensive searchable database of publicly available patent petition documents filed with the United States Patent and Trademark Office ("USPTO").
  • By utilizing Petition.ai's extensive searchable database, patent attorneys, patent agents, and their support teams can efficiently search through hundreds of thousands of petition documents to readily find ones with similar issues and/or fact patterns.
  • Facts, filters, and features of the database:
    Facts - The searchable database includes 500,000 petition documents from 200,000 patent applications filed since 2013.
  • With the launch of its comprehensive searchable database of patent petition documents, Petition.ai begins its quest to build a robust portfolio of patent-related databases.

Accenture Federal Services Awarded a Position on USPTO Intelligent Automation Innovation Support Services Contract

Retrieved on: 
Thursday, June 18, 2020
Banking, Software, Networks, Professional services, Data management, Technology, White House, Federal Government, Security, Other Professional Services, Finance, Other Technology, Public policy, Government, Consulting, Service companies, Intellectual property law, Consulting, Accenture, United States trademark law, ACN, United States Patent and Trademark Office

Accenture Federal Services (AFS), a subsidiary of Accenture, (NYSE: ACN), has been awarded a position on the U.S. Patent and Trademark Office (USPTO) Intelligent Automation and Innovation Support Services (IAISS) blanket purchase agreement (BPA), a multi-award contract vehicle.

Key Points: 
  • Accenture Federal Services (AFS), a subsidiary of Accenture, (NYSE: ACN), has been awarded a position on the U.S. Patent and Trademark Office (USPTO) Intelligent Automation and Innovation Support Services (IAISS) blanket purchase agreement (BPA), a multi-award contract vehicle.
  • It will set a standard framework for innovation for the USPTO and could serve as a model across the federal government.
  • Were excited to help the USPTO, through the collaborative environment of the Accenture Federal Digital Studio, to leverage innovative solutions to enhance mission operations, said Ira Entis, Accenture Federal Services Growth and Strategy lead.
  • Accenture Federal Services, a wholly owned subsidiary of Accenture (NYSE: ACN), is a U.S. company with offices in Arlington, Virginia.

Guident Ltd Company Update: Appointment of Science Board Members and Award of an Additional Patent

Retrieved on: 
Tuesday, June 16, 2020
Intellectual property law, Intellectual property organizations, International Searching and Preliminary Examining Authorities, Patent offices, United States Patent and Trademark Office, United States trademark law, Patent

LONDON and BOCA RATON, Fla., June 16, 2020 /PRNewswire-PRWeb/ --Guident Ltd, the developer of software apps for autonomous vehicles and land-based delivery drones, announces the appointment of science advisory board members and the award of a U.S. patent.

Key Points: 
  • LONDON and BOCA RATON, Fla., June 16, 2020 /PRNewswire-PRWeb/ --Guident Ltd, the developer of software apps for autonomous vehicles and land-based delivery drones, announces the appointment of science advisory board members and the award of a U.S. patent.
  • Guident is pleased to announce the appointment of Professor Naphtali Rishe, Professor Hayder Radha and Dr. Marielle S. Gross to its Science Advisory Board.
  • Rishe is an Eminent Chair Professor in Computer Science and has authored many books on database management, location-based data, health informatics, and high performance computing.
  • Additionally, Guident has announced the forthcoming issuance of patent #10,699,580 from the USPTO, entitled "Methods and Systems for Emergency Handoff of an Autonomous Vehicle."

AAXLL Responds to Trademark Lawsuit Regarding Charlotte's Web Strain

Retrieved on: 
Thursday, June 11, 2020
United States trademark law, Brand management, Product management, Intellectual property law, Trademark, United States Patent and Trademark Office, Office action, Patent and Trademark Office, Charlotte's Web, United States patent law

AAXLL's filing vigorously disputes CWI's central allegation that Charlotte's Web is not the name of a strain of hemp.

Key Points: 
  • AAXLL's filing vigorously disputes CWI's central allegation that Charlotte's Web is not the name of a strain of hemp.
  • AAXLL CEO Joseph Maskell notes that CWI itself referred to "the Charlotte's Web strain" in its own 2019 public offering documents.
  • Maskell also states, "U.S. federal trademark law already dictates that cultivar or strain names are generic from the get-go, so the Charlotte's Web name of the strain was never protected as a trademark.
  • In October 2019, the United States Patent & Trademark Office rejected CWI's trademark application for "Charlotte's Web" in a nonfinal Office Action.

AAXLL Responds to Trademark Lawsuit Regarding Charlotte's Web Strain

Retrieved on: 
Thursday, June 11, 2020
United States trademark law, Brand management, Product management, Intellectual property law, Trademark, United States Patent and Trademark Office, Office action, Patent and Trademark Office, Charlotte's Web, United States patent law

AAXLL's filing vigorously disputes CWI's central allegation that Charlotte's Web is not the name of a strain of hemp.

Key Points: 
  • AAXLL's filing vigorously disputes CWI's central allegation that Charlotte's Web is not the name of a strain of hemp.
  • AAXLL CEO Joseph Maskell notes that CWI itself referred to "the Charlotte's Web strain" in its own 2019 public offering documents.
  • Maskell also states, "U.S. federal trademark law already dictates that cultivar or strain names are generic from the get-go, so the Charlotte's Web name of the strain was never protected as a trademark.
  • In October 2019, the United States Patent & Trademark Office rejected CWI's trademark application for "Charlotte's Web" in a nonfinal Office Action.

Covalon Granted Key Antimicrobial Patents in the United States, Canada, and Europe

Retrieved on: 
Wednesday, June 3, 2020
Intellectual property law, International Searching and Preliminary Examining Authorities, Patent offices, United States trademark law, United States Patent and Trademark Office

Covalon's Antimicrobial Silicone-based Wound Dressing patent has been granted in the United States by the USPTO, in Canada by the CIPO, and in Europe by the EPO.

Key Points: 
  • Covalon's Antimicrobial Silicone-based Wound Dressing patent has been granted in the United States by the USPTO, in Canada by the CIPO, and in Europe by the EPO.
  • This antimicrobial patent is integral to the Company's CovaClear platform technology and the Company's IV Clear, MediClear PreOp, and SurgiClear products.
  • The USPTO also granted the Company a patent for a Method for the Reduction of Microbial Skin Flora, which protects the Company's novel product MediClear PreOp.
  • IV Clear, MediClear, and SurgiClear are registered trademarks of Covalon Technologies Ltd. in Canada, the United States and the United Kingdom.

Patent Issuance Allowed for Single-Use or Short-Term Nitric Oxide Delivery Device

Retrieved on: 
Thursday, May 28, 2020
Intellectual property law, Asthma, Respiratory therapy, Health, United States Patent and Trademark Office, United States trademark law, Inhaler

(OTCQB: NUMD), a medical device company which investigates and develops applications and devices for nitric oxide delivery in the medical field, today announced that the United States Patent and Trademark Office (USPTO) has allowed the issuance of a patent for a single-use or short-term use nitric oxide inhaler.

Key Points: 
  • (OTCQB: NUMD), a medical device company which investigates and develops applications and devices for nitric oxide delivery in the medical field, today announced that the United States Patent and Trademark Office (USPTO) has allowed the issuance of a patent for a single-use or short-term use nitric oxide inhaler.
  • Typically, nitric oxide delivery devices are large, electronically complex devices that are used primarily in neonatal intensive care units.
  • Jeff Robins, Chief Executive Officer of Nu-Med Plus, stated, This patent allowance is a significant achievement for our Company and can help open new patient markets.
  • The Utah-based medical device company is currently in the process of filing for FDA approval for their NMP-200 hospital nitric oxide delivery unit.